MedTrace Logo

Performance of a New REsting Pressure Index During Invasive Angiography Compared To Adenosine Hyperemic FFR

NCT03237169 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-05-11

No results posted yet for this study

Summary

To test the feasibility and diagnostic accuracy of a new automated pressure derived resting index (Pd/Pamin), using FFR as gold standard, in de novo coronary lesions in which invasive physiological evaluation is warranted.

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Cardiovascular Research Foundation, New York

    collaborator OTHER

  • Centro Hospitalar Lisboa Ocidental

    lead OTHER_GOV

Principal Investigators

  • Luis Raposo, MD · Centro Hospitalar de Lisboa Ocidental

  • Sergio Bravo Baptista, MD, PhD · Hospital Fernando da Fonseca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-28
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • United States
  • France
  • Italy
  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03237169 on ClinicalTrials.gov